Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

Completed · Not applicable

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

In partnership with a large Medicare Advantage (MA) insurer (Humana, Inc.) and as part of a Center for Medicare and Medicaid Innovation demonstration program of Value-Based Insurance Design (VBID), the investigators propose to study a randomized controlled quality improvement trial in which Humana randomized MA beneficiaries with COPD to receive proactive outreach for a VBID benefit that provided large reductions in cost-sharing for their maintenance inhalers and telephone-based COPD medication management services in 2020 and 2021. The investigators will analyze changes in racial disparities for inhaler fills, clinical outcomes, health care spending, and acute care utilization.

Key facts

Study ID
NCT05497999
Run by
Harvard Medical School (HMS and HSDM)
People needed
19113
Starts
2020-01-07
Expected to finish
2022-12-31
Last updated by the study team
2023-03-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.